Back to today’s briefing

Story perspectives

Stage Four Cancer Survivor Defies Odds with Experimental Treatment

3/16/2025

25 4

Summary

Story summary

At 62, Allen Rapert faced a daunting stage four squamous cell carcinoma diagnosis in May 2023. Choosing hope over surgery, he pursued an experimental treatment in Mexico, combining pulsed electric field ablation with immunotherapy. Miraculously, just seven months later, he emerged cancer-free, a testament to the treatment's impressive 85% success rate for advanced cancers.

1 of 1

Story summary

At 62, Allen Rapert faced a daunting stage four squamous cell carcinoma diagnosis in May 2023. Choosing hope over surgery, he pursued an experimental treatment in Mexico, combining pulsed electric field ablation with immunotherapy. Miraculously, just seven months later, he emerged cancer-free, a testament to the treatment's impressive 85% success rate for advanced cancers.